Pregnancy is a stress test that can reveal later-life health risks for mother and child. Preeclampsia is an early warning sign for cardiometabolic diseases, but many at risk are not identified in time. Our aim is to improve early prediction and prevention of pregnancy complications and related long-term diseases. By bringing together research groups, we will study metabolic, immune, and genetic factors, and follow health changes from before pregnancy to childhood. The project is important for patients and families because earlier risk detection can lead to healthier pregnancies, fewer complications, and better long-term health outcomes. The project will be carried out through a joint workshop and use of modern diagnostic tools to support personalised prevention and care.

The event is going to be organised in October 2026 in Budapest (Hungary) by the PRE-TWIN SCREEN and MSOP-PRE ERAPerMed project leaders. The event will engage a broad spectrum of translational stakeholders critical to achieving its objectives including scientific and clinical experts and consortium members of the two ERAPerMed projects as well as the Immunology of preeclampsia and the 4PMEDICINE networks. These include international preeclampsia researchers, obstetricians, midwives, research nurses, and perinatal care specialists. Early-stage researchers and trainees will actively participate in the networking event. Additional key stakeholders will also include diagnostic product manufacturers, health technology assessment experts, implementation specialists, physicians, healthcare providers, clinics, policy makers, regulatory authorities, patient advocacy organisations, and ethics experts. Incorporating these stakeholders ensures multi-dimensional knowledge integration, real-world applicability, ethical soundness, and social inclusivity, strengthening both the scientific quality and the long-term impact of the event. Stakeholders will engage in plenary lectures, workshops, and networking sessions, providing expert input and feedback on methodological approaches, interpretation, and clinical translation.